Osaic Holdings’s Entera Bio ENTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-16,777
Closed -$30.2K 7472
2024
Q3
$30.2K Hold
16,777
﹤0.01% 5104
2024
Q2
$36.7K Buy
16,777
+15,277
+1,018% +$33.4K ﹤0.01% 4921
2024
Q1
$2.5K Buy
+1,500
New +$1.66K ﹤0.01% 6385
2023
Q3
Sell
-750
Closed -$633 7427
2023
Q2
$633 Buy
+750
New +$640 ﹤0.01% 6996

Other funds holding ENTX

Osaic Holdings's ENTX Position: Q4 2024 in Review

Osaic Holdings sold out of Entera Bio (ENTX) in Q4 2024, closing a stake of 16,777 shares — an estimated $30.2K sold.

Osaic Holdings first reported a position in ENTX in Q2 2023 and held it in 4 quarters. The position peaked at $36.7K in Q2 2024. 14 funds tracked by Wall St. Rank hold ENTX as of Q4 2024.

  • Osaic Holdings reported no remaining Entera Bio position as of Q4 2024 after selling out during the quarter.
  • Osaic Holdings sold 16,777 Entera Bio shares in Q4 2024, an estimated $30.2K.
  • Osaic Holdings first reported a position in Entera Bio in Q2 2023 and held it in 4 quarters.
  • Osaic Holdings's Entera Bio position peaked at $36.7K in Q2 2024.
  • 14 funds tracked by Wall St. Rank held Entera Bio as of Q4 2024.

Based on Osaic Holdings's 13F filing for Q4 2024, filed 7 Feb 2025.